Clinical trial
Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove…
NCT00006099 · Ludwig Institute for Cancer Research, Other · Terminated
Key facts
| NCT number | NCT00006099 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer |
| Official title | Pilot Trial of Humanized 3S193 Monoclonal Antibody (hu3S193) in Presurgical Patients With Ovarian Cancer |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological |
| Interventions | Monoclonal antibody hu3S193 |
| Enrollment | 1 |
| Start date | Aug 2, 2000 |
| Primary completion | Feb 26, 2002 |
| Completion | Aug 12, 2002 |
| First posted | Dec 23, 2003 |
| Last update posted | Oct 4, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: